Business
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan
About this update from Abcellera Biologics Inc.
[{"type":"text","content":" VANCOUVER, British Columbia--(BUSINESS WIRE)--\nAbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.\n\nA live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be available through the same link following the presentation.\n\nAbout AbCellera Biologics Inc.\n\nAbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20251208404823/en/\n\nInquiries\nMedia: Tiffany Chiu; [email protected], +1(236)521-6774\nPartnering: Murray McCutcheon, Ph.D.; [email protected], +1(604)559-9005\nInvestor Relations: Peter Ahn; [email protected], +1(778)729-9116\n\nSource: AbCellera Biologics Inc.","length":3080,"tagName":"div"}]